Scientific Programme 2017

 

Thursday 6 April 2017

0830-1000Workshop – Hot HIV topics in Latin America
Chairs: Ernesto Martinez, Cali, Colombia, Alejandro Afani and
Carlos Beltran, Santiago, Chile

0830-0850HIV in Latin America “a young epidemic
Pedro Zitko, Santiago, Chile
0850-0910Ladies first “always a problem
Isabel Cassetti, Buenos Aires, Argentina
0910-0930Too late to care “the same old story
Ana P Celi de la Torre, Quito, Ecuador
0930-1000Roundtable: Facing up the epidemic in Latin America: form evidence to action
Speakers, chairs and audience

1000-1015Official Opening

1015-1045Can we end AIDS and Eradicate Hepatitis C? A path forward 
Carl Dieffenbach, USA

1045-1115Is it possible to cure HIV infection? A clinician’s perspective
Steven Deeks, USA

1115-1130Coffee

1130-1300Guidelines: Roundtable discussion
The role of integrase inhibitors: An overview
Anton Pozniak, UK
WHO guidelines: An overview
Stefano Vella, Italy

Perspectives from the region
Brazil – Adele Schwartz Benzaken
Argentina – Carlos Zala
Mexico – Luis Mosqueda

1300-1400Lunch

1400-1430Treatment of Hepatitis CWhere are we now?
Mario Pessoa, Brazil

1430-1500Review Key Data since the 2016 Americas Congress
CROI
Luis Soto-Ramirez, Mexico
Other events/publication

Ricardo Diaz, Brazil

1500-1630 Oral abstracts

1630-1700Coffee

1700-1830Industry Symposium

Friday 7 April 2017

0900-1030Industry Symposium

1030-1045Coffee

1045-1145Treating Adolescents with HIV
Session in collaboration with the International AIDS Society (IAS)
Overview
Linda-Gail Bekker, South Africa

Followed by an expert panel discussion
Adolescents perspective
Daisy Machado, Brazil
MTCT – paediatric perspective
Jorge Pinto, Brazil

1145-1300Barriers to treatment success in Hep C
Access to drugs
Reinfection/patient education
When will I not treat anymore

1300-1400Lunch

1400-1500Case Session ‘Challenging cases in Hepatitis’ and interactive session
Hepatitis C
Mario Pessoa, Brazil
Hepatitis B
Triple co-infected case
Jorge Santana, Puerto Rico

1500-1515Coffee

1515-1645PrEP – Where are we? what are the issues and what’s on the horizon?
An overview
Esper Kallas, Brazil
Rolling out PrEP
Beatriz Grinsztejn, Brazil
Unseen benefits of PrEP programmes in countries
Florentino Badial Hernandez, Mexico

The importance of PrEP from a community perspective
Owen Ryan, Switzerland

1645-1700Coffee

1700-1830Industry Symposium

Saturday 8 April 2017

0900-1000Industry Workshop

1000-1015Coffee

1015-1145Public health perspectives
Session in collaboration with the Pan American Health Organization (PAHO)
Viral hepatitis B and C in the Americas
Massimo Ghidinelli, USA
What would it take to eliminate hepatitis B & C in the region of the Americas?
Homie Razavi, USA
Access to compassionate treatment for HCV in Argentina: review of one years
experience
Gabriella Vidiella, Argentina
Expanding access to HCV treatment: Treatment priorities and overcoming barriers
Adele Schwartz Benzaken, Brazil
Elimination of HBV perinatal transmission: how far from achievement?
Chloe Thio, USA

1145-1315The 90s in the Americas
Testing
Treatment
Pedro Cahn, Argentina
Retention in care/adherence
Carlos Beltran, Chile
Prioritization of treatment: Is it necessary?
Mauro Schechter, Brazil

1315-1415Lunch

1415-1530‘Challenging cases in HIV’
Interactive case session in collaboration with the International Antiviral Society-USA
(IAS-USA)
Issues in Opportunistic infections: Focus on TB prevention
Prepping for Pre exposure Prophylaxis
Antiretroviral Therapy: What to start

1530-1600Treatment as prevention in HCV and drug users

1600-1630New ART strategies and the future of ART?

Daniel Kuritzkes, USA

1630-1645Official Close